BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30784024)

  • 1. Liver fibrosis is associated with cognitive impairment in people living with HIV.
    Ciccarelli N; Fabbiani M; Brita AC; De Marco R; Grima P; Gagliardini R; Borghetti A; Cauda R; Di Giambenedetto S
    Infection; 2019 Aug; 47(4):589-593. PubMed ID: 30784024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fibrosis is associated with cognitive impairment in HIV-positive patients.
    Ciccarelli N; Fabbiani M; Grima P; Limiti S; Fanti I; Mondi A; Gagliardini R; D'Avino A; Borghetti A; Cauda R; Di Giambenedetto S
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19722. PubMed ID: 25397468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients.
    Fabbiani M; Ciccarelli N; Castelli V; Soria A; Borghetti A; Colella E; Moschese D; Valsecchi M; Emiliozzi A; Gori A; De Luca A; Bandera A; Di Giambenedetto S
    J Neurovirol; 2019 Dec; 25(6):866-873. PubMed ID: 31281946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus.
    Santos M; Corma-Gómez A; Fernandez-Fuertes M; González-Serna A; Rincón P; Real LM; Pineda JA; Macías J
    J Infect; 2023 Jan; 86(1):41-46. PubMed ID: 36410455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.
    Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S
    Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
    Hodowanec AC; Lee RD; Brady KE; Gao W; Kincaid S; Plants J; Bahk M; Mackman N; Landay AL; Huhn GD
    BMC Infect Dis; 2015 Apr; 15():190. PubMed ID: 25884329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of steatotic liver disease and non-alcoholic steatohepatitis on cognitive impairment in people living with HIV: A cross-sectional study.
    Han WM; Hiransuthikul A; Holroyd KB; Apornpong T; Lwin HM; Gatechompol S; Ubolyam S; Kerr S; Avihingsanon A;
    HIV Med; 2023 Dec; 24(12):1233-1243. PubMed ID: 37975283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
    Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
    HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono- Infection and HCV/HIV Co-Infection.
    Kiatbumrung R; Chuaypen N; Payungporn S; Avihingsanon A; Tangkijvanich P
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2191-2197. PubMed ID: 30139224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
    Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
    J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?
    Mohr R; Schierwagen R; Schwarze-Zander C; Boesecke C; Wasmuth JC; Trebicka J; Rockstroh JK
    Medicine (Baltimore); 2015 Dec; 94(50):e2127. PubMed ID: 26683921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection.
    Bruno R; Sacchi P; Cima S; Maiocchi L; Patruno SF; Klersy C; Barbarini G; Zuccaro V; Camma C; Filice G
    Dig Liver Dis; 2011 Jul; 43(7):575-8. PubMed ID: 21596630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction.
    Barokar J; McCutchan A; Deutsch R; Tang B; Cherner M; Bharti AR
    J Neurovirol; 2019 Dec; 25(6):792-799. PubMed ID: 31281947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.
    Verlinden W; Bourgeois S; Gigase P; Thienpont C; Vonghia L; Vanwolleghem T; Michielsen P; Francque S
    J Ultrasound Med; 2016 Jun; 35(6):1299-308. PubMed ID: 27151906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients.
    Merchante N; Rivero A; de Los Santos-Gil I; Merino D; Márquez M; López-Ruz MA; Rodríguez-Baño J; Del Valle J; Camacho A; Sanz-Sanz J; Macías J; Pérez-Camacho I; Gómez-Mateos J; Moro A; Pineda JA
    Gut; 2009 Dec; 58(12):1654-60. PubMed ID: 19625279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
    Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
    J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection.
    Li Vecchi V; Soresi M; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; Terranova A; Vizzini G; Montalto G
    Int J Infect Dis; 2012 May; 16(5):e397-402. PubMed ID: 22425495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients.
    Mazzola G; Adamoli L; Calvaruso V; Macaluso FS; Colletti P; Mazzola S; Cervo A; Trizzino M; Di Lorenzo F; Iaria C; Prestileo T; Orlando A; Di Marco V; Cascio A
    Infection; 2019 Jun; 47(3):409-415. PubMed ID: 30519966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Sánchez-Conde M; Montes Ramírez ML; Bellón Cano JM; Caminoa A; Alvarez Rodríguez F; González Garcia J; Miralles Martín P; Bernardino de la Serna I; Bernardo de Quirós JC; Arribas López JR; Cosín Ochaíta J; Pascual Pareja JF; Alvarez E; Berenguer JB
    J Viral Hepat; 2011 Jul; 18(7):e278-83. PubMed ID: 21129129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.